Patel Hersha, Jeve Yadava B, Sherman Susan M, Moss Esther L
Department of Gynaecology, University Hospitals Leicester, Leicester, UK.
School of Psychology, Keele University, Staffordshire, UK.
Sex Transm Infect. 2016 Sep;92(6):474-9. doi: 10.1136/sextrans-2015-052341. Epub 2016 Jan 20.
BACKGROUND: The human papillomavirus (HPV) vaccine is recommended for adolescent girls in many European countries, however there is huge variation in vaccine uptake. METHODS: A mixed methods systematic review to ascertain the level of HPV and HPV vaccine knowledge that exists among European adolescents. Two electronic databases, Ovid Medline and PsychInfo, were searched from origin to September 2014. Meta-analysis was performed for the two primary outcome measures ('have you heard of HPV?' and 'have you heard of the HPV vaccine?'), assessing for the correlation between gender and knowledge. This was supplemented with meta-synthesis for the remaining associations and secondary outcomes. RESULTS: 18 papers were included in the final review. Overall European adolescents had poor understanding of basic HPV and HPV vaccine knowledge. Meta-analysis identified that female adolescents are more likely to have heard of HPV (n=2598/5028 girls versus n=1033/3464 boys; OR 2.73, 95% CI 1.86-3.99) and the HPV vaccine (n=1154/2556 girls versus n=392/2074 boys; OR 5.64, 95% CI 2.43-13.07), compared to males. Age, higher education and a positive vaccination status were also associated with increased awareness. There was limited appreciation of more detailed HPV knowledge and uncertainty existed regarding the level of protection offered by the vaccine and the need for cervical screening post vaccination. CONCLUSIONS: The delivery of HPV education to European adolescents needs to be re-evaluated, since at present there appears to be significant deficiencies in their basic knowledge and understanding of the subject. Increasing HPV knowledge will empower adolescents to make informed choices regarding participation with HPV related cancer prevention health strategies.
背景:在许多欧洲国家,人乳头瘤病毒(HPV)疫苗被推荐用于青春期女孩,但疫苗接种率存在巨大差异。 方法:采用混合方法进行系统评价,以确定欧洲青少年对HPV及HPV疫苗的了解程度。检索了两个电子数据库,即Ovid Medline和PsychInfo,检索时间从建库至2014年9月。对两项主要结局指标(“你听说过人乳头瘤病毒吗?”和“你听说过人乳头瘤病毒疫苗吗?”)进行荟萃分析,评估性别与知识之间的相关性。对其余关联和次要结局进行荟萃综合分析作为补充。 结果:最终评价纳入18篇论文。总体而言,欧洲青少年对HPV及HPV疫苗的基本知识了解不足。荟萃分析表明,与男性青少年相比,女性青少年更有可能听说过人乳头瘤病毒(2598/5028名女孩,而1033/3464名男孩;比值比2.73,95%可信区间1.86 - 3.99)和人乳头瘤病毒疫苗(1154/2556名女孩,而392/2074名男孩;比值比5.64,95%可信区间2.43 - 13.07)。年龄、高等教育程度和阳性疫苗接种状态也与认知度提高相关。对于更详细的HPV知识了解有限,对于疫苗提供的保护水平以及接种疫苗后是否需要进行宫颈筛查存在不确定性。 结论:需要重新评估对欧洲青少年开展的HPV教育,因为目前他们对该主题的基本知识和理解似乎存在重大缺陷。增加HPV知识将使青少年能够就参与HPV相关癌症预防健康策略做出明智选择。
Cochrane Database Syst Rev. 2018-5-9
Cochrane Database Syst Rev. 2021-9-6
BMC Public Health. 2021-11-10
Front Public Health. 2025-6-5
J Prim Care Community Health. 2017-10
Int J Mol Sci. 2025-6-10
Vaccines (Basel). 2024-7-6